AMBEY — Ambey Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.10bn
- IN₹1.48bn
- IN₹1.31bn
Annual cashflow statement for Ambey Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30.9 | 48.3 | 62.2 | 54.3 | 60.4 |
| Depreciation | |||||
| Non-Cash Items | 40.2 | 30.1 | 18.3 | 16.5 | 26.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -75.9 | -52 | -15.7 | -227 | -457 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 27.4 | 56.1 | 94.4 | -131 | -345 |
| Capital Expenditures | -12.1 | -7.59 | -30.9 | -51.1 | -135 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.402 | 0.058 | 0.062 | -1.71 | 0.217 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -11.7 | -7.53 | -30.9 | -52.8 | -135 |
| Financing Cash Flow Items | -41 | -30.5 | -18.4 | -17.8 | -54.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14.9 | -50.8 | -62.3 | 184 | 483 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.858 | -2.22 | 1.22 | -0.331 | 3.63 |